Can quality-adjusted life year avoidance help in oncology drug reimbursement decisions?
J Oncol Pract
.
2008 Jan;4(1):8.
doi: 10.1200/JOP.0711501.
Author
John E Calfee
PMID:
20859437
PMCID:
PMC2793928
DOI:
10.1200/JOP.0711501
No abstract available